Choledochal cyst

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:480501Q44.4
Who is this for?
Show terms as
4Active trials6Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Choledochal cyst (also known as bile duct cyst or choledochal malformation) is a congenital condition characterized by cystic dilatation of the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. These cysts can occur at various points along the biliary tree and are classified into five types (Todani classification), with Type I (fusiform dilatation of the common bile duct) being the most common. The condition primarily affects the hepatobiliary system but can have secondary effects on the pancreas and gastrointestinal tract. The classic triad of symptoms includes abdominal pain (typically in the right upper quadrant), jaundice (yellowing of the skin and eyes), and a palpable abdominal mass, though this complete triad is present in only a minority of patients. In infants, the condition may present with obstructive jaundice and acholic (pale) stools, while older children and adults more commonly experience recurrent abdominal pain, cholangitis (infection of the bile ducts), or pancreatitis. If left untreated, choledochal cysts carry a significant risk of complications including biliary cirrhosis, portal hypertension, cholangiocarcinoma (bile duct cancer), and recurrent cholangitis. The standard treatment for choledochal cysts is surgical excision of the cyst with reconstruction of the biliary tract, most commonly through a Roux-en-Y hepaticojejunostomy (connecting the remaining bile duct directly to a loop of small intestine). Complete cyst excision is strongly recommended over simple drainage procedures because of the well-documented risk of malignant transformation in retained cyst tissue, which increases with age. The condition is more prevalent in females and in East Asian populations, particularly in Japan where incidence rates are notably higher. Early diagnosis and surgical intervention generally lead to excellent long-term outcomes.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

6 events
Dec 2025Host-Microbe Interactions in Biliary Dilatation

Beijing Tsinghua Chang Gung Hospital

TrialNOT YET RECRUITING
Jul 2025Efficacy and Safety of Surgical Treatment for Type IVa CBD

Beijing Tsinghua Chang Gung Hospital

TrialRECRUITING
Mar 2025Biliary Dilatation National Special Disease Cohort in China

Beijing Tsinghua Chang Gung Hospital

TrialRECRUITING
Jul 2024The Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis

Zhujiang Hospital

TrialRECRUITING
Nov 2022Timing of Operation in Children With a Prenatal Diagnosis of Choledochal Cyst

Guangzhou Women and Children's Medical Center — NA

TrialNOT YET RECRUITING
Oct 2022Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center

María Teresa Moreno Asencio

TrialENROLLING BY INVITATION

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Choledochal cyst.

4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

4 recruitingView all trials with filters →
Other4 trials
Efficacy and Safety of Surgical Treatment for Type IVa CBD
Actively Recruiting
PI: Shuo Jin, PhD (Beijing Tsinghua Changgeng Hospital) · Sites: Beijing, Beijing Municipality · Age: 080 yrs
Biliary Dilatation National Special Disease Cohort in China
Actively Recruiting
PI: Shuo Jin, PhD (Beijing Tsinghua Chang Gung Hospital) · Sites: Beijing, Beijing Municipality · Age: 080 yrs
The Application of Digital Intelligent Diagnostic and Therapeutic Technology in Biliary Dilation Diagnosis
Actively Recruiting
· Sites: Guangzhou, Guangdong · Age: 1675 yrs
Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center
Enrolling by Invitation
· Sites: Huelva

Specialists

6 foundView all specialists →
SP
Shuo Jin, PhD
AUSTIN, TX
Specialist
PI on 5 active trials
AA
Azlanudin Azman
Specialist
PI on 1 active trial1 Choledochal cyst publication
LP
LEWIN MAITE, MD, PhD
Specialist
PI on 1 active trial
MM
Meral Gunay-Aygun, M.D.
BETHESDA, MD
Specialist
PI on 2 active trials
HP
Huijun Chen, Ph.D.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Choledochal cyst.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Choledochal cystForum →

No community posts yet. Be the first to share your experience with Choledochal cyst.

Start the conversation →

Latest news about Choledochal cyst

No recent news articles for Choledochal cyst.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Choledochal cyst

What is Choledochal cyst?

Choledochal cyst (also known as bile duct cyst or choledochal malformation) is a congenital condition characterized by cystic dilatation of the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. These cysts can occur at various points along the biliary tree and are classified into five types (Todani classification), with Type I (fusiform dilatation of the common bile duct) being the most common. The condition primarily affects the hepatobiliary system but can have secondary effects on the pancreas and gastrointestinal tract. The classic tria

How is Choledochal cyst inherited?

Choledochal cyst follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Choledochal cyst?

Yes — 4 recruiting clinical trials are currently listed for Choledochal cyst on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Choledochal cyst?

6 specialists and care centers treating Choledochal cyst are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.